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ABSTRACT
Recent advances in genome-wide association
studies (GWAS) have enabled us to identify thou-
sands of genetic variants (GVs) that are associated
with human diseases. As next-generation
sequencing technologies become less expensive,
more GVs will be discovered in the near future.
Existing databases, such as NHGRI GWAS Catalog,
collect GVs with only genome-wide level signifi-
cance. However, many true disease susceptibility
loci have relatively moderate P values and are not
included in these databases. We have developed
GWASdb that contains 20 times more data than
the GWAS Catalog and includes less significant
GVs (P< 1.0 103) manually curated from the litera-
ture. In addition, GWASdb provides comprehensive
functional annotations for each GV, including
genomic mapping information, regulatory effects
(transcription factor binding sites, microRNA target
sites and splicing sites), amino acid substitutions,
evolution, gene expression and disease associ-
ations. Furthermore, GWASdb classifies these GVs
according to diseases using Disease-Ontology Lite
and Human Phenotype Ontology. It can conduct
pathway enrichment and PPI network association
analysis for these diseases. GWASdb provides an
intuitive, multifunctional database for biologists
and clinicians to explore GVs and their functional
inferences. It is freely available at http://jjwanglab
.org/gwasdb and will be updated frequently.
INTRODUCTION
Thousands of genetic variants (GVs) associated with
human traits and diseases have been identified by
genome-wide association studies (GWAS). The advent of
high throughput technologies, such as next-generation
sequencing and very high-density microarrays, enable us
to capture genome-wide variation on a much larger scale.
With increasing sample sizes, GWAS studies based on
these technologies will produce more information at
higher resolutions. We will be able to detect many traits/
diseases associated GVs, such as single nucleotide poly-
morphisms (SNPs), copy number variations (CNVs),
and insertions and deletions (Indels) (1,2).
To understand the underlying regulatory and metabolic
significance of these GVs, we have to consider biological
evidences from different sources. However, in developing
databases and web resources to integrate multidimension-
al functional annotations, researchers will inevitably en-
counter the following difficulties: (i) Searching and
gathering GWAS results from published data for a
specific trait/disease can be tedious and time-consuming.
Researchers have to locate the publications by searching
PubMed or other databases, and then gather GVs by
manual curation either from the main text or from
related supplementary materials for each publication.
(ii) Individual curation lacks a universal criterion for
data handling, which might cause data inconsistency and
consequently affects the quality of the downstream
analysis. (iii) Inference of the functional role of these
GVs from heterogeneous databases will also be a chal-
lenge. Information (genomic elements, genetic and
disease associated attributes) from different databases
(such as dbSNP, HapMap, RefSeq, Ensemble and
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OMIM) needs to be gathered. If the information is not
readily available, functional prediction will need to be per-
formed using various available software or web servers.
Fortunately, several databases and tools have been de-
veloped to cope with these problems. The NHGRI GWAS
Catalog has collected more than 5800 GVs from published
GWAS (up to August 2011). The database used GWAS
studies reporting at least one GV with P< 5.0 108, and
the collected GVs were limited to P< 1.0 105 (3). This
database also contains some statistical features
including odds ratios and estimated risk allele frequencies.
Johnson and O’Donnell have published a full gene-
annotated GWAS database, which contains 56 411
GWAS genotype–phenotype associations with a threshold
P< 1.0 103 (4). GWAS Central (previously named
HGVbaseG2P) is another manually curated database
that provides a centralized compilation of high level
summary data from genetic association studies (5).
Other databases also focus on data integration of GVs
from GWAS, such as dbGaP PheGenI (6), Genetic
Association Database (GAD) (7), HuGE Navigator (8),
Varietas (9) and Snpedia. Many bioinformatics tools have
been developed to quickly locate genome elements around
GVs and to infer their putative functions, such as
SNPselector (10), SNP Function Portal (11), F-SNP
(12), SNPit (13), SNPLogic (14), SNPnexus (15), SCAN
(16), GWAS analyzer (17) and pfSNP (18). These
Web-based resources continually strive to provide a com-
prehensive knowledge base of the characteristics and func-
tions of GVs.
However, existing resources also have limitations in sat-
isfying the increasing demands of current GWAS research:
(i) Many true disease susceptibility loci have relatively
moderate P values which are ignored in existing databases.
GVs with moderate effect sizes, usually filtered by
strict cutoffs, can be directly related to diseases through
gene–gene interaction in the context of regulatory
networks and pathways (19). (ii) Most of the existing data-
bases focus only on one or several aspects of the function-
al annotations, and not on GV-disease relationships. An
integrative, comprehensive, up-to-date GWAS-based
knowledge base that focuses on disease classification is
needed.
Here, we present GWASdb, a user friendly database
that combines collections of GVs from GWAS together
with their functional annotations and disease classifica-
tions. We aim to provide an integrative, multidimensional
functional annotation portal to help researchers and clin-
icians maximize the usage of the most recent GWAS data.
The database provides the following information: (i) In
addition to all the GVs annotated in the NHGRI
GWAS Catalog, we manually curated the GVs that are
marginally significant (P< 1.0 103) collected from sup-
plementary materials of each original publication. (ii) We
provide extensive functional annotations for these GVs.
(iii) The GVs have been manually classified according to
disease using Disease-Ontology Lite (DOLite) and Human
Phenotype Ontology (HPO). The database can be used to
conduct gene-based pathway enrichment and PPI network
association analysis for diseases with sufficient variants.
DATABASE DESIGN AND CONTENT
We provide an intuitive, well-organized and easy-to-use
web interface that allows users to explore the GVs from
different perspectives, including genome, disease, gene
regulation and protein interactions. Users can quickly
search and locate a queried region by inputting the
dbSNP id, gene symbol and chromosome region, or by
directly clicking the data point on the plot of the GWAS
overview. We have also developed a web-based genome
viewer (Gviewer) to dynamically display the related infor-
mation. Furthermore, to facilitate communication with
other servers, we provide web service interfaces for
machine-based large-scale data retrieval. We anticipate
the database can facilitate follow-up analysis of specific
diseases and can help researchers generate hypotheses by
integrating multidimensional information concerning the
target GV. The overall structure of our database is shown
in Figure 1.
Data curation and collection
One major source of data for GWASdb was from the
NHGRI GWAS Catalog. The GWAS Catalog has col-
lected data on thousands of GVs from the literature,
adopting a stringent criterion to ensure data consistency
and integrity. SNP-trait associations for each GV gathered
from each paper were limited to P< 1.0 105, and the
database also restricted the number of SNP-trait associ-
ations extracted from each paper to 50 (3). We extended
the scope of this database by using a relatively loose cutoff
of P< 1.0 103 for data from each paper, and where
possible GVs were included from supplementary mater-
ials. We used the same standards for other criteria,
including P values derived from the largest sample size,
population selected from a combined analysis or the
largest one. Our purpose was to incorporate more GVs
with moderate P values and to have more comprehensive
functional annotations. At this current stage, we have
gathered 70 411 GVs, 64 000 more than in the NHGRI
GWAS Catalog (see Supplementary Data). Other
well-organized GWAS databases also incorporated were
Johnson and O’Donnell (4), dbGaP PheGenI (6), GAD
(7), GWASCentral (5) and PharmGKB (20). We found
many overlapping GVs annotated in these databases,
which we combined by selecting only the most significant
ones from the redundant GVs. We also omitted the GVs
that we had already included from the NHGRI GWAS
Catalog. In total, we obtained 146 537 GVs from the con-
solidation of several databases, 20 times more than in the
NHGRI GWAS Catalog (see Supplementary Data). All
the GVs can be viewed at either the whole genome level or
at the chromosome level using the circular genome plot.
Constructing GV functional annotation
All the collected GVs were mapped to the latest
dbSNP132 database. We then integrated comprehensive
annotations from various sources for these GVs. These
annotations were systematically divided into seven
categories as follows: GV summary, genomic mapping,
regulatory effect, amino acid substitution, evolution,
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gene expression and disease annotation (Table 1). For
each category, we investigated the possible functional
roles of each selected GV. For example, in the category
of regulatory effect, we computed the affinity changes
caused by different alleles of each GV, such as the
affinities between transcriptional factors and their
binding sites (21–23), microRNAs and their targets (23),
and predicted splicing sites (18). The statistical signifi-
cances of the binding affinity changes were calculated
based on permutations of the binding partners (24).
We further calculated how the annotated GVs are
distributed in different genomic regions. As shown in
Figure 2a, 43.5% of all GVs are in the gene regions,
such as intron, nonsense, missense, cds-indel, cds-synon,
frameshift, 30-UTR, 50-UTR, 30-nearGene and
50-nearGene, as defined by dbSNP132. The rest of the
GVs (56.5%) are located in intergenic regions, which
are areas that contain enhancers, promoter elements and
many other long range regulators, and thus may be
involved in gene regulation and regulatory networks
(25). The top 15 traits/diseases with the most abundant
GVs in our database are shown in Figure 2b.
Mapping of GVs using DOLite and HPO
DOLite is a simplified annotation of gene–disease associ-
ations. It was constructed from the OBO Foundry Disease
Ontology (26). DOLite uses 561 independent nodes to
describe gene–disease associations and is highly suited
for GV-disease mapping in our database. We were able
to successfully map 70% of our GVs into these nodes.
However, DOLite does not include other phenotypes,
such as height, weight and addiction, so another
ontology database, HPO (27), was used. We were able
to successfully map the rest of the GVs in our database
in terms of HPO.
Disease-oriented analysis using DOLite and HPO
The mapping of GVs to diseases enables us to perform
disease level meta-analysis. It is important to understand
Figure 1. The overview of GWASdb database design. GWASdb consists of three main functions: precise scientific curation and resources integration
on GWAS, comprehensive annotation of genetic variants and disease-oriented analysis in terms of DOLite and HPO.
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the underlying mechanism of SNP–disease association,
particularly in the context of pathways and networks.
Our database allows users to perform meta-analysis on
multiple studies targeting the same disease, defined by a
unique term in DOLite or HPO. We used the KGG
package (28) to search for enriched pathways or
protein–protein interaction networks (PPI). We omitted
the disease terms that contained less than 400 GVs
because pathway and PPI enrichment analysis need a
large dataset of genes.
WEB INTERFACE AND DATA QUERYING
The GWASdb web site provides six straightforward com-
ponents: Guidance, GWAS overview, Gviewer, DOLite
Viewer, HPO Tree Viewer and Customized Page. These
help researchers locate and explore the GVs of interest and
its related functional annotations.
The guidance page
The GWAS guidance page is the front page of the
database. The user should first read this page to get a
general idea on the contents and how to use various func-
tions of the database. On the left-upper corner of the page,
there is a sliding menu with menu items that the users can
start with. If the users want to get all the GVs in the whole
genome level, they can click on the ‘Overview’ item. If they
are interested in a particular disease, they can start from
either ‘DOLITE’ or ‘HPO’ items. If they want to analyze a
list of SNPs of they own, they can start from the
‘CUSTOMIZED’ item.
The GWAS overview page
The GWAS overview page displays a circular GWAS plot
showing the global view of the top GVs in each human
chromosome. The dots in the plot represent the top two
GVs from each study and different colors represent differ-
ent diseases (Figure 3a). Other information is shown as
spectral plots in the inner circles of the plot, such as
CNV hotpots, dbSNP density, HapMap density, 1000
genome density and OMIM gene distribution
(Figure 3b). By clicking on the ideogram of each chromo-
some, the user will be presented with a new circular plot
displaying a single chromosome showing the top five GVs
from each disease. By clicking on a single dot, users will be
brought to the Gviewer page and general information of
GV will be displayed, such as dbSNP id, P value, study
source and DOLite catalog number.
The Gviewer
The Gviewer is a web-based genome browser that dynam-
ically displays the different tracks related to the queried
GV. Gviewer currently provides four tracks (GV,
RefGene, OMIM Gene and DGV) that show the
elements around the target GV. More tracks will be
added in the future. Users can either click on the arrow
buttons or drag the tracks to show the surrounding
regions. By clicking elements on the track, users can get
detailed information in a popup message box. When a GV
is clicked, comprehensive functional annotations of this
GV will be displayed on the right pane, which will
update with the user actions in the Gviewer. To improve
the user experience, selecting different tabs does not switch
to another page and waiting time is kept to a minimum
because the page loading is asynchronous and the page
rendering is progressive.
For example, if a user inputs the dbSNP id (rs437179) in
top search bar or by clicking this GV in GWAS overview
plot, the user will be automatically forwarded to Gviewer.
This shows the GV location in the gene body of SKIV2L,
an OMIM gene (600478), together with copy number
variants. By clicking on each annotation tab in the right
pane, users will obtain the following detailed functional
annotations about this GV: (i) it is associated with
rheumatoid arthritis (P value of 6.15E-20); (ii) it was
reported in HapMap and 1000 genome project with
average heterozygosity of 0.39; (iii) it has an miRNA
(hsa-mir-1236) located in its upstream region; (iv) its two
alleles significantly change the transcriptional factor
binding site affinities (transcriptional factors: LM105
and GAMYB); (v) it is a non-synonymous SNP; (vi) it is
located in the conserved region undergoing positive
selection; (vii) it is associated with the differential
Figure 2. Classifications of GVs from the genic regions and according to the traits/diseases in GWASdb. (a) The proportion of GV/gene transcripts
with different functional properties in the genic regions (total representing 43.5% of all GVs in GWASdb). (b) The Top 15 traits/diseases which have
the most significant GVs in database based on DOLite catalog.
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co-expression between two genes (DEFB4 and OAS1);
(viii) it has extensive variants and diseases association
(OMIM: 600478; DGV: 3602, 36507; GAD: 557471,
557472, 557473) (see Supplementary Figure S1).
The DOLite viewer and HPO viewer
To demonstrate the disease/trait classifications of these
GVs, we provide the DOLite viewer and HPO viewer.
GWASdb displays an interactive Manhattan Plot viewer
for easy visualization of GVs mapped to a DOLite node or
HPO tree. By selecting each disease or phenotype node, a
Manhattan Plot will be instantly drawn on the left pane,
with each dot representing a GV. The detailed information
on all GVs associated with this disease is simultaneously
shown on the right pane. Users can hover the mouse over
the GV dot to view a brief description of the GV. When
the GV dot is clicked, detailed information will be high-
lighted on the right pane. By clicking the arrow icon on
the highlighted information, the user can continue to the
Gviewer page to see the detailed functional annotation of
this GV. We also provide pathway and PPI analysis for
DOLite terms or HPO nodes that total more than 400
GVs. Two additional tabs can be accessed for gene-based
pathway analysis calculated from the KGG package (28)
and PPI network analysis rendered by Cytoscape (29)
(Supplementary Figure S2).
Searching the GWASdb database
On the front page, users can perform a quick search in any
of the five search categories of dbSNP id, gene symbol,
chromosome region, DOLite and HPO phenotype terms.
The system will show instant hints messages when the user
only inputs part search terms or show alert messages if the
search term is not recognized. After clicking the ‘Go’
button, the server will display different views depending
on which search category was selected. For example, if
dbSNP id was queried, the system will display the high-
lighted SNP in the Gviewer pane together with compre-
hensive annotations on the right pane. If the SNP id is in
an older version format, the system will automatically
convert it to the latest version and process the query.
For gene or genomic region searches, the system will
show all GVs in that region in the Gviewer pane
together with literature information on the right pane.
For disease or phenotype queries, a Manhattan Plot will
be displayed on the left pane. The user can then click on a
particular GV on the plot and the system will display the
Gviewer page with that GV highlighted.
The customized page
This customized page allows users to study a list of GVs of
their choice. The users will input the list of GVs and select
their disease of interest, either as a DOLite term or a HPO
node. The server will search our local database for all the
SNPs associated with this disease and compare them with
the input GVs. A hypergeometric test will be performed to
test whether the input GVs have any significant overlap
with the GVs in the database. The overlapping and
non-overlapping GVs will be displayed in different
colors in a Manhattan Plot. By clicking on the dots on
the plot, users can further explore the functional annota-
tions of each GV.
Figure 3. Illustration of the circular GWAS plot. (a) Overview of the circular GWAS plot, dots show the top two GVs for each study.
(b) A description of each of the components in the plot.
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Database implementation and downloading
GWASdb is a web-based query tool designed with
Service-oriented architecture (SOA). We used jQuery
and Raphae¨l JavaScript frameworks as the frontend to
build Gviewer, which ensures high usability of web
pages, and we used MySql as the backend database.
Database sharding is used to handle the large amount of
SNP data. To facilitate the communication with other
servers, we have provided web service interfaces for
machine-based large-scale data retrieval, which were built
using Apache CXF technology (see Supplementary Data).
All the functional annotations in the Gview page can be
downloaded in batch, by clicking the ‘Get All Information
in JSON’ on the right panel of the Gview page.
DISCUSSION
The GWASdb database can satisfy the demands of the
scientific community for the exploration of ever increasing
amounts of GWAS data. Many published bioinformatics
tools have targeted functional annotations of GVs. We
performed a function-oriented comparison with existing
tools (see Supplementary Table S2). Using rich web appli-
cation techniques, GWASdb offers great convenience to
researchers for analysis of their GWAS data. Researchers
can quickly locate and fetch the GVs of interest and
examine the genetic information and functional annota-
tions in great detail. Furthermore, they can explore
pathway and PPI networks in the context of disease-
oriented meta-analysis. This platform combined with
other resources will be an effective tool to study the
underlying disease mechanism in GVs. The GWASdb in-
tegrative database portal will be a valuable resource for
researchers and clinicians.
The GWASdb focuses on specific features and functions
of GWAS GVs and their disease classifications. The
GWASdb database has collected GVs from six resources
so far (NHGRI GWAS Catalog, Johnson and O’Donnell,
dbGaP PheGenI, GAD, GWASCentral and PharmGKB).
Due to inconsistency in data formats and difficulty of data
curation, we did not delve into the experimental and
sample description of each GWAS, such as population-
related information, individual ratio, geographic region
and mode of recruitment. Instead, we provide PubMed
links for each GV in our database so that users can
easily trace the information from the original publications.
Since our purpose was to integrate potentially useful GVs
from the literature, we used a predefined cutoff
(P< 1.0 103) as our curation threshold. This cutoff
was used because we found most reported moderate
SNPs have GWAS significance between 102 and 104
(19,30). Nevertheless, lowering the P value cutoff will in-
evitably increase our false positives. The users can use the
‘customized’ page to hand pick the GVs of interest. There
are experimental methods that can reduce the false posi-
tives, for example, validation of GWAS results from
an independent cohort, or functional study. Compu-
tational methods can also be used to reduce the false
positives. For example, it was recently reported that
trait/disease-associated GVs are more likely to be
expression Quantitative Trait Locus (eQTL). We can use
eQTLs to filter the false positive and reveal the true asso-
ciation profile of the study (31).
With the advent of personal genome sequencing
projects such as the 1000 Genomes Project, many novel
mutations and disease-causing loci will be discovered in
the near future. We will constantly recruit new GVs into
our database as new GWAS data become available. At the
same time, we will incorporate new bioinformatics algo-
rithms and tools to improve the accuracy of functional
annotations. In the next stage, we will incorporate SNPs
that are not found by GWAS studies, but are in close
Linkage Disequilibrium (LD) with the SNPs in
GWASdb. This will greatly enhance the utility of this
database because there are disease-causing GVs that
were not covered by GWAS arrays. Besides, we also aim
to collect data from important genome regions such as
eQTLs, long non-coding RNA and DNA methylation
sites in the next version of GWASdb, because SNPs in
those regions may pose positive or negative effects on
gene regulation. We will add more tracks to the Gviewer
page to allow users to view more functional elements, such
as SNP density, haplotype plot and important regulators.
For GV annotation, we plan to integrate more data
sources or pre-compute the functional predictions using
recognized algorithms. The GWASdb database is freely
available at http://jjwanglab.org/gwasdb and will be
updated frequently.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Figures 1–2, Supplementary Tables 1–2.
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